Retrieve available abstracts of 19 articles: HTML format
Single Articles
April 2025
SHARMA J, Zhou F, Moreira AL Pulmonary Adenocarcinoma Updates: Histology, Cytology, and Grading.
Arch Pathol Lab Med. 2025;149:e82-e86. PubMedAbstract available
FORTAREZZA F, Pezzuto F, Maniglio S, Marzullo A, et al Adverse Prognostic Impact of Transitional and Pleomorphic Patterns in Pleural
Nonepithelioid Mesothelioma: Insights From Comprehensive Analysis and Reticulin
Stain.
Arch Pathol Lab Med. 2025;149:347-353. PubMedAbstract available
MUKHOPADHYAY S Thoracic Frozen Section Pitfalls: Lung Adenocarcinoma Versus Selected Mimics.
Arch Pathol Lab Med. 2025;149:e93-e99. PubMedAbstract available
MORAN CA Uncommon Tumors of the Lung: Recently Described and Rediscovered Tumors.
Arch Pathol Lab Med. 2025;149:e87-e92. PubMedAbstract available
March 2025
KANATHANAVANICH M, Li X, Boac B, Bose S, et al Robotic-Assisted Bronchoscopy for the Diagnosis of Lung Lesions: Experience With
the Use of Frozen Sections as an Aid to Confirm the Localization of Lesions
During the Procedure.
Arch Pathol Lab Med. 2025;149:288-292. PubMedAbstract available
February 2025
LI J, Fu X The Presence of Small-Size Circulating Tumor Cells Predicts Worse Prognosis in
Non-Small Cell Lung Cancer Patients.
Arch Pathol Lab Med. 2025;149:111. PubMed
November 2024
HUSAIN AN, Chapel DB, Attanoos R, Beasley MB, et al Guidelines for Pathologic Diagnosis of Mesothelioma: 2023 Update of the Consensus
Statement From the International Mesothelioma Interest Group.
Arch Pathol Lab Med. 2024;148:1251-1271. PubMedAbstract available
VILLALBA JA, Terra SB, Pitel B, Knight SM, et al Clinicopathologic and Molecular Characteristics of Resected Thoracic Mass Lesions
in the Pediatric Population: A 25-Year Institutional Experience From a Tertiary
Care Center.
Arch Pathol Lab Med. 2024;148:1209-1217. PubMedAbstract available
October 2024
DACIC S Neoadjuvant Therapy and Lung Cancer: Role of Pathologists.
Arch Pathol Lab Med. 2024 Oct 25. doi: 10.5858/arpa.2024-0203. PubMedAbstract available
September 2024
QI Z, Ha T, Feng W, Karnoub M, et al Analytical and Clinical Validation of the Oncomine Dx Target Test to Assess HER2
Mutation Status in Tumor Tissue Samples From Patients With Non-Small Cell Lung
Cancer Treated With Trastuzumab Deruxtecan in the DESTINY-Lung01 and
DESTINY-Lung02 Studies
Arch Pathol Lab Med. 2024 Sep 20. doi: 10.5858/arpa.2024-0014. PubMedAbstract available
July 2024
CECCHINI MJ Pathways to Precision: Guideline for Programmed Death Ligand-1 and Tumor Mutation
Burden Testing to Support the Selection of Immune Checkpoint Therapies in Lung
Cancer.
Arch Pathol Lab Med. 2024;148:754-756. PubMed
May 2024
HUNG YP, Chirieac LR Molecular and Immunohistochemical Testing in Mesothelioma and Other Mesothelial
Lesions.
Arch Pathol Lab Med. 2024;148:e77-e89. PubMedAbstract available
BLAAUWGEERS H, Filipello F, Lissenberg-Witte B, Doglioni C, et al Loose Tumor Cells in Pulmonary Arteries of Lung Adenocarcinoma Resection
Specimens: No Correlation With Survival, Despite High Prevalence.
Arch Pathol Lab Med. 2024;148:588-594. PubMedAbstract available
April 2024
SUN Q, Li W, Yang D, Lin PP, et al The Presence of Small-Size Circulating Tumor Cells Predicts Worse Prognosis in
Non-Small Cell Lung Cancer Patients.
Arch Pathol Lab Med. 2024 Apr 18. doi: 10.5858/arpa.2023-0455. PubMedAbstract available
SHOLL LM, Awad M, Basu Roy U, Beasley MB, et al Programmed Death Ligand-1 and Tumor Mutation Burden Testing of Patients With Lung
Cancer for Selection of Immune Checkpoint Inhibitor Therapies: Guideline From the
College of American Pathologists, Association for Molecular Pathology,
International As
Arch Pathol Lab Med. 2024 Apr 16. doi: 10.5858/arpa.2023-0536. PubMedAbstract available
MILLER LJ, Holmes IM, Lew M An Updated Contextual Approach to Mesothelial Proliferations in Pleural Effusion
Cytology Leveraging Morphology, Ancillary Studies, and Novel Biomarkers.
Arch Pathol Lab Med. 2024;148:409-418. PubMedAbstract available
March 2024
BLATNIK A, Dragos VS, Blatnik O, Stegel V, et al A Population-Based Study of Patients With Small Cell Carcinoma of the Ovary,
Hypercalcemic Type, Encompassing a 30-Year Period.
Arch Pathol Lab Med. 2024;148:299-309. PubMedAbstract available
December 2023
NAMBIRAJAN A, Sood R, Khatoon W, Malik PS, et al Concordance of Immunohistochemistry and Fluorescence In Situ Hybridization in the
Detection of Anaplastic Lymphoma Kinase (ALK) and Ros Proto-oncogene 1 (ROS1)
Gene Rearrangements in Non-Small Cell Lung Carcinoma: A 4.5-Year Experience
Highlighting Ch
Arch Pathol Lab Med. 2023 Dec 6. doi: 10.5858/arpa.2023-0229. PubMedAbstract available
HOCKING AJ, Thomas EM, Prabhakaran S, Jolley A, et al Molecular Characterization of Testicular Mesothelioma and the Role of Asbestos as
a Causative Factor.
Arch Pathol Lab Med. 2023;147:1446-1450. PubMedAbstract available